Skip to content

Mounjaro 15 mg: the maximum adult dose

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

The short answer

Mounjaro 15 mg once weekly is the maximum dose for adults on the FDA label. You reach it in 2.5 mg steps, after at least 4 weeks on 12.5 mg, when more blood sugar control is needed. A fill is four single-dose pens for 28 days. LillyDirect self-pay starts at $499 a month, which is $6,487 a year.

Source: LillyDirect self-pay

Key takeaways

  • Mounjaro 15 mg once weekly is the adult maximum. Pediatric patients stop at 10 mg.
  • The earliest first injection is after 20 weeks, and the label doesn't require anyone to reach 15 mg.
  • If 15 mg doesn't give the blood sugar control you need, your prescriber decides the next steps.
  • At LillyDirect's self-pay starting price, a year at 15 mg is $6,487.
  • Commercial plan covers Mounjaro? The savings card can lower a fill to as little as $25.

What the label says about Mounjaro 15 mg

Once weeklyA labelled maintenance doseAt least 28 days before any increase

Maximum dose in adults.

The maximum dosage of MOUNJARO is: 15 mg injected subcutaneously once weekly in adults. 10 mg injected subcutaneously once weekly in pediatric patients.

Comes as: KwikPen (multi-dose, 4 weekly doses); Multi-dose vial (4 weekly doses); Single-dose pen; Single-dose vial.

FDA label: Revised: 8/2026 (DailyMed version 40)

Mounjaro dose schedule from the label

Put it on a calendar with the titration schedule builder. Only your prescriber decides when, and whether, your dose changes.

Supply per fill

Pack sizes from the "How supplied" section of the Mounjaro label
FormDoses per deviceDoses per fillDays per fillFills per year
KwikPen (multi-dose, 4 weekly doses)442813
Multi-dose vial (4 weekly doses)442813
Single-dose pen142813
Single-dose vial11752

Track run-out and refill dates with the supply tracker.

Mounjaro 15 mg: every way to pay, cheapest first

This table uses the 15 mg dose. Prices can differ at other doses, so use the cost calculator for yours. Swipe the table sideways to see conditions and sources.

Cost per fill, including any telehealth membership
How you payFormPer fillCost per mgConditionsSource
Manufacturer savings card (commercial insurance, drug covered)Single-dose pen$25$0.42
Conditions

Commercial drug insurance that covers Mounjaro. Pay as little as $25 for a 1-, 2- or 3-month fill; maximum savings $150 per 1-month, $300 per 2-month or $450 per 3-month fill, and $1,950 per calendar year; up to 13 fills per year. Month is 28 days and up to 4 pens. Government beneficiaries excluded. Card expires 12/31/2026.

mounjaro.lilly.com
LillyDirect self-paySingle-dose pen$499$8.32
Conditions

Self-pay only through LillyDirect; the same $499/month starting price is shown for every strength (2.5, 5, 7.5, 10, 12.5 and 15 mg). Prescription required; additional taxes and fees may apply; purchase terms apply.

lilly.com
Manufacturer savings card (commercial insurance, drug not covered)Single-dose pen$499$8.32
Conditions

Commercial drug insurance that does not cover Mounjaro. Pay as low as $499 per 1-month fill (28 days, up to 4 pens); maximum savings $647 per month and $8,411 per calendar year; up to 13 fills per year. Government beneficiaries excluded. Card expires 12/31/2026.

mounjaro.lilly.com

Savings-card and Medicare prices apply only if you are eligible. "From" prices that telehealth providers advertise are shown only at the lowest strength.

If you miss a dose of Mounjaro

  • You can move your weekly day, as long as there are at least 3 days between doses.

    The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours).
  • If it has been more than 4 days, skip it and take your next dose on your usual day.

    If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.
  • If it has been 4 days or less, take it now and carry on with your usual weekly day.

    If a dose is missed, instruct patients to administer MOUNJARO as soon as possible within 4 days (96 hours) after the missed dose.

Enter your own dates in the missed-dose helper. If you are unsure, call your prescriber or pharmacist; never take two doses to catch up.

Fifteen milligrams is where the Mounjaro ladder ends for adults. The label says it briefly: “The maximum dosage of MOUNJARO is: 15 mg injected subcutaneously once weekly in adults.” Pediatric patients stop at 10 mg, so this page is about adults only.

Reaching 15 mg

The route is fixed: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, then 15 mg, with at least 4 weeks on each. At the minimum pace, the top dose begins after 20 weeks. Under the label, each increase is made only if additional glycemic control (blood sugar control) is needed, so 15 mg is for people whose blood sugar still needs more control at every lower strength.

Once you’re at 15 mg, there’s no next step. The titration schedule tool shows the whole path with dates.

What the label reports at 15 mg

The label’s adult studies tested 15 mg throughout. HbA1c is a blood test that measures average blood sugar. At week 40:

  • Monotherapy (Mounjaro on its own): average HbA1c change of -1.7 on 15 mg against -0.1 on placebo (an inactive treatment). Average body-weight change of -7.8 kg against -1.0 kg.
  • Added to metformin, against semaglutide 1 mg: average HbA1c change of -2.3 on Mounjaro 15 mg and -1.9 on semaglutide 1 mg.

The label also describes a cardiovascular outcomes trial, which tracks heart and blood vessel events, with a median follow-up of 210.1 weeks. Mounjaro was non-inferior to dulaglutide for major cardiovascular events, meaning it was shown to be no worse by the trial’s measure. The estimated hazard ratio, which compares risk between the two groups, was 0.92, and superiority (being better than dulaglutide) was not established.

Side effects were reported most often at this strength in the placebo-controlled pool: nausea in 18%, diarrhea in 17% and vomiting in 9%, against 4%, 9% and 2% on placebo. Gastrointestinal (stomach and gut) reactions led 6.6% of people on 15 mg to stop treatment.

The cost of staying at the top dose

Since 15 mg is a dose people stay on, the yearly figure is the useful one. LillyDirect self-pay starts at $499 a month. Over 13 fills of 28 days, that’s $6,487 a year. A first year that begins at 2.5 mg and steps up costs the same, $6,487, because every strength shares one price.

Other figures at this dose:

  • List price: $1,112.16 per fill of four pens.
  • Savings card, plan covers Mounjaro: as little as $25 per fill.
  • Savings card, commercial plan doesn’t cover it: $499 per one-month fill.

The cost calculator lets you enter your own copay, and the Mounjaro cost page explains the card’s limits and how Medicare Part D applies.

Supply and forms

A carton of four single-dose 15 mg pens is a 28-day fill. The label also lists 15 mg as a single-dose vial, a multi-dose vial and a KwikPen with four weekly doses. The Mounjaro guide covers each one, and the dosing hub puts this schedule in context.

Where to get Mounjaro

Some links on this page are affiliate links: if you sign up through them we may earn a commission at no extra cost to you. The cheapest legitimate option is always listed first, and payouts never affect rankings. How we make money.

  1. 1. Manufacturer savings card (commercial insurance, drug covered)

    $25 per fill at 15 mg

    Single-dose pen

    Source: mounjaro.lilly.comGo to the program page

  2. 2. LillyDirect self-pay

    $499 per fill at 15 mg

    Single-dose pen

    Source: lilly.comGo to the program page

  3. 3. Manufacturer savings card (commercial insurance, drug not covered)

    $499 per fill at 15 mg

    Single-dose pen

    Source: mounjaro.lilly.comGo to the program page

Ranked by cost only. Manufacturer and government programs never pay us. To see every option for your situation, try the cheapest-path quiz.

Frequently asked questions

Is 15 mg the highest dose of Mounjaro?

Yes, for adults. The label says the maximum dosage of Mounjaro is 15 mg injected once weekly in adults and 10 mg once weekly in pediatric patients. No higher strength is made in any form. If 15 mg doesn't give you the blood sugar control you need, your prescriber decides the next steps.

How long does it take to get to Mounjaro 15 mg?

The label starts at 2.5 mg and allows 2.5 mg increases after at least 4 weeks on each dose. Taking all five earlier steps at the minimum interval, your first 15 mg injection comes after 20 weeks. Increases are made only if more glycemic control is needed, so the label doesn't require anyone to reach 15 mg.

What did the trials show for Mounjaro 15 mg?

At week 40 of the label's monotherapy trial (Mounjaro on its own), average HbA1c change on 15 mg was -1.7 against -0.1 on placebo, and average body-weight change was -7.8 kg against -1.0 kg. In the trial added to metformin, HbA1c change was -2.3 on Mounjaro 15 mg and -1.9 on semaglutide 1 mg.

How often do people stop Mounjaro 15 mg because of side effects?

The label reports that 6.6% of people taking 15 mg in placebo-controlled trials stopped treatment because of gastrointestinal (stomach and gut) adverse reactions, compared with 0.4% of people on placebo. In the same pool, nausea was reported by 18% on 15 mg and diarrhea by 17%, against 4% and 9% on placebo.

Sources (8)

  1. 1.
    FDA label (DailyMed): Mounjaro prescribing information, section 14.2, Table 4
    “Table 4: Results at Week 40 in a Trial of MOUNJARO as Monotherapy in Adult Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control with Diet and Exercise. HbA1c (%) - Change at Week 40: Placebo: -0.1; MOUNJARO 5 mg: -1.8; MOUNJARO 10 mg: -1.7; MOUNJARO 15 mg: -1.7”
  2. 2.
    FDA label (DailyMed): Mounjaro prescribing information, section 14.2, Table 4
    “Table 4: Results at Week 40 in a Trial of MOUNJARO as Monotherapy in Adult Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control with Diet and Exercise. Body Weight (kg) - Change at Week 40: Placebo: -1.0; MOUNJARO 5 mg: -6.3; MOUNJARO 10 mg: -7.0; MOUNJARO 15 mg: -7.8”
  3. 3.
    FDA label (DailyMed): Mounjaro prescribing information, section 14.3, Table 5
    “Table 5: Results at Week 40 in a Trial of MOUNJARO versus Semaglutide 1 mg in Adult Patients with Type 2 Diabetes Mellitus Added to Metformin. HbA1c (%) - Change at Week 40: Semaglutide 1 mg: -1.9; MOUNJARO 5 mg: -2.0; MOUNJARO 10 mg: -2.2; MOUNJARO 15 mg: -2.3”
  4. 4.
    FDA label (DailyMed): Mounjaro prescribing information, section 14.6
    “Over a median follow-up of 210.1 weeks, MOUNJARO was non-inferior to dulaglutide for reducing the occurrence of MACE-3. The estimated hazard ratio for time to first MACE was 0.92 (95.3% CI: 0.83, 1.01) for MOUNJARO compared to dulaglutide. Superiority to dulaglutide was not established.”
  5. 5.
  6. 6.
  7. 7.
  8. 8.